Nicotine and Nicotinic Receptor Drugs

This publication has 136 references indexed in Scilit:

• Meta‐analysis of early nonmotor features and risk factors for Parkinson disease
  Annals of Neurology, 2012
• Environmental tobacco smoke and Parkinson's disease
  Movement Disorders, 2011
• Adjunctive Varenicline Treatment with Antipsychotic Medications for Cognitive Impairments in People with Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial
  Neuropsychopharmacology, 2011
• α4β2 nicotinic acetylcholine receptor partial agonists with low intrinsic efficacy have antidepressant-like properties
  Behavioural Pharmacology, 2011
• Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats
  Neuropharmacology, 2011
• Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis
  Trends in Pharmacological Sciences, 2010
• Pathophysiological roles for purines
  2010
• nAChR agonist-induced cognition enhancement: Integration of cognitive and neuronal mechanisms
  Biochemical Pharmacology, 2009
• Serum Urate as a Predictor of Clinical and Radiographic Progression in Parkinson Disease
  Archives of Neurology, 2008
• Plasma Urate and Risk of Parkinson's Disease
  American Journal of Epidemiology, 2007